Showing results (2361-2370 of 2,371) with videos related to

Sort By:
Pageof 238
Future Medicinal Chemistry|August 6, 2026
Design, synthesis and dual anticancer and antibacterial evaluation of novel 1,3,4-oxadiazole-2-thiol derivatives targeting EGFR and DNA Gyrase B: integrated docking, DFT and ADMET studiesIla M Ram, Jay B Maheta, Darshna K Lakhnotra, et al.
Future Medicinal Chemistry|August 10, 2026
Asymmetric benzazole derivatives as dual antibiofilm and anti-wall teichoic acid agents against Staphylococcus aureusMine Buga Aktekin, Zehra Oksuz, Mehmet Abdullah Alagoz, et al.
Future Medicinal Chemistry|August 11, 2026
Novel thioether and thioester-based derivatives as promising antibacterial agents with antioxidant potential: design, synthesis, and in silico studiesAya H Othman, Menna M A Abd El-Mageed, Faten Farouk, et al.
Future Medicinal Chemistry|August 13, 2026
Harnessing the quinoline core for targeted cancer therapyCong-Jun Liu, Wei-Wen Huang, Jun-Jie Wang, et al.
Future Medicinal Chemistry|August 20, 2026
Chalcone-indole hybrid scaffolds as promising anticancer drug candidates: a mini-reviewYafei Zhuang, Yanjing Cheng, Danchen Zhao, et al.
Future Medicinal Chemistry|August 7, 2026
Latest developments in small molecule inhibitors of cysteine protease B as antileishmanial drugsKarla Joane da Silva Menezes, Sonaly Lima Albino, João Vitor Vieira da Silva, et al.
Future Medicinal Chemistry|August 14, 2026
Advancing cancer drug discovery through the integration of machine learning and high-throughput screeningKamil Herbetko, Katarzyna Herbetko, Magdalena Mikołajek, et al.
Future Medicinal Chemistry|September 1, 2026
EGFR kinase inhibitors from novel thiazole derivatives: synthesis, anticolon cancer, docking, and ADME studiesAmani M R Alsaedi, Alaa M Abu Alnjaa, Amel S Younes, et al.
Future Medicinal Chemistry|September 8, 2026
Organometallic compounds as antimicrobial agents: emerging chemical types, mechanistic insights and future directionsGonzalo Scalese, Dinorah Gambino
Future Medicinal Chemistry|September 2, 2026
Rational drug design, synthetic and artificial intelligence approaches for bioactive heterocycles: advances and perspectivesDebajit Dewan, Bhupender Nehra, Rajarshi Nath, et al.
Pageof 238